Zarembinski Christopher MD is categorized under Hospitals in Los Angeles, CA and active since 2004.
Zarembinski Christopher MD was established in 2004, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Hospitals business, which does work in the B2C market, and is classified as a Hospitals, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Christopher Zarembinski at the company’s single location by writing to 444 South San Vicente Boulevard # 1101, Los Angeles, California CA 90048 or by phoning (310) 423-9600. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Zarembinski Christopher MD |
| Contact Person: | Christopher Zarembinski |
| Address: | 444 South San Vicente Boulevard # 1101, Los Angeles, California 90048 |
| Phone Number: | (310) 423-9600 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hospitals |
| SIC Code: | 8062 |
| NAICS Code: | 6211110 |
| Share This Business: |
Zarembinski Christopher MD was started in 2004 to provide professional Hospitals under the SIC code 8062 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Christopher Zarembinski for inquiries that concern Zarembinski Christopher MD by calling the company number (310) 423-9600, as your correspondence is most welcome. Additionally, the physical location of the single location of Zarembinski Christopher MD can be found at the coordinates 34.0689,-118.37486 as well as the street address 444 South San Vicente Boulevard # 1101 in Los Angeles, California 90048.
For its online presence, you may visit Zarembinski Christopher MD’s website at and engage with its social media outlets through on Twitter and on Facebook.